Sotera Health (NASDAQ:SHC) Inc. (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies. Nelson Labs provides microbiological, analytical chemistry, shelf life, packaging and environmental testing, as well as consulting services to help clients navigate FDA, ISO and other international regulatory standards. The Nordion segment, based in Canada, supplies gamma irradiators, radiopharmaceutical isotopes and related equipment for healthcare and food sterilization applications.
Founded in 2017 following a carve‐out of specialized sterilization and testing businesses by private equity, Sotera Health completed its initial public offering in November 2021. The company maintains a global footprint, with more than 70 facilities across North America, Europe, Asia-Pacific and Latin America. Its network of laboratories, sterilization plants and technical experts supports customers throughout all stages of product development, from design validation to commercial launch and ongoing quality assurance.
Leadership at Sotera Health includes President and Chief Executive Officer Walter Rosebrough, who has steered the company’s growth initiatives and operational integrations since its public listing. Under his direction, Sotera Health has expanded capacity, invested in new technologies and strengthened its regulatory services to meet rising demand in critical healthcare and life science markets.
